Tokyo, Sept. 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063053) titled 'Clinical trial to evaluate the changes in skin condition after cleansing' on Sept. 26.

Study Type: Interventional

Study Design: Basic Design - Cross-over Randomization - Randomized Blinding - Single blind -investigator(s) and assessor(s) are blinded Control - Active

Primary Sponsor: Institute - FANCL Corporation

Condition: Condition - Healthy subjects Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To investigate whether cleansing changes the epidermal condition, and whether those changes vary depending on the type of cleanser Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Cleansing of the test sites a predetermined number of times using Cleanser A Interventions/Control_2 - Cleansing of the test sites a predetermined number of times using Cleanser B

Eligibility: Age-lower limit - 30 years-old

Gender - Male and Female Key inclusion criteria - Healthy male and female subjects aged 30 years or older and younger than 60 years Key exclusion criteria - 1) Subjects with severe atopic dermatitis. 2) Subjects receiving hormone therapy. 3) Subjects with a history of allergy to cosmetics or medications, or those with self-reported sensitive skin. 4) Subjects who are pregnant, may be pregnant, or are breastfeeding. 5) Subjects with severe cardiac, renal, or hepatic disease, suspected cardiovascular disease, or a history of any of these conditions. 6) Subjects who are currently undergoing, or have undergone within the previous 3 months, treatments that affect skin function on the volar forearm, including chemical peels, laser treatments, or physician-prescribed medications (e.g. hydroquinone, high-concentration vitamin C preparations, or retinoic acid). 7) Subjects currently participating in another clinical trial. 8) Subjects with extensive wounds, warts, and/or rashes on the volar forearm. 9) Subjects deemed unsuitable for participation in the trial by the principal investigator. Target Size - 10

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 09 Month 15 Day Anticipated trial start date - 2026 Year 10 Month 15 Day Last follow-up date - 2027 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072161

Disclaimer: Curated by HT Syndication.